Insulet Corporation
Manufacturer of tubeless, wearable subcutaneous insulin delivery systems and associated digital health platforms. Offers multi‑day disposable wearable insulin delivery devices, controller and smartphone apps for insulin dosing and device management, integrations with interoperable continuous glucose monitoring (CGM) sensors, published clinical evidence from pivotal and prospective trials, pharmacy and mail‑order distribution pathways, and patient support programs including benefits checks, trial supplies and copay/financial assistance. Coverage options include pharmacy benefits under Medicare Part D and commercial payer channels.
Industries
N/A
Nr. of Employees
small (1-50)
Products
Disposable tubeless wearable automated insulin delivery system (wearable device + controller/app)
A disposable, tubeless wearable subcutaneous insulin delivery device designed for multi‑day continuous delivery and intended to operate as part of an automated insulin delivery system when integrated with a compatible CGM and controller or smartphone app.
Tubeless insulin management configuration (wearable device + personal controller)
Configuration pairing a wearable disposable delivery device with a personal controller or compatible smartphone app for basal and bolus delivery and user interface functions.
Device interaction simulator mobile application
Mobile application to simulate device interactions for hands‑on practice including bolus delivery, device change workflows and activity features to support caregiver and user training.
Adhesive overlay accessory for wearable device
Adhesive overlay accessory to improve device adhesion during activities such as sports or water exposure.
Disposable tubeless wearable automated insulin delivery system (wearable device + controller/app)
A disposable, tubeless wearable subcutaneous insulin delivery device designed for multi‑day continuous delivery and intended to operate as part of an automated insulin delivery system when integrated with a compatible CGM and controller or smartphone app.
Tubeless insulin management configuration (wearable device + personal controller)
Configuration pairing a wearable disposable delivery device with a personal controller or compatible smartphone app for basal and bolus delivery and user interface functions.
Device interaction simulator mobile application
Mobile application to simulate device interactions for hands‑on practice including bolus delivery, device change workflows and activity features to support caregiver and user training.
Adhesive overlay accessory for wearable device
Adhesive overlay accessory to improve device adhesion during activities such as sports or water exposure.
Services
Online and phone services to verify insurance coverage (including Medicare Part D and select government channels), estimate copays, and determine eligibility for copay assistance.
Limited supply trial programs and one‑time starter kit or copay card dispense for eligible new users administered with pharmacy partners based on benefits checks and program terms.
Fulfillment through mail‑order, specialty pharmacies and major retail pharmacy chains for ongoing supply of disposable devices and starter kits.
Training sessions (including remote and eLearning), user guides, video tutorials, certified trainer support and 24/7 customer care for device setup, troubleshooting and effective use.
Collection and recycling pilot for used disposable device components to reduce device waste in pilot regions.
Membership program offering community newsletters, opportunities to participate in surveys and share user experience to inform product development and support outreach.
Online and phone services to verify insurance coverage (including Medicare Part D and select government channels), estimate copays, and determine eligibility for copay assistance.
Limited supply trial programs and one‑time starter kit or copay card dispense for eligible new users administered with pharmacy partners based on benefits checks and program terms.
Fulfillment through mail‑order, specialty pharmacies and major retail pharmacy chains for ongoing supply of disposable devices and starter kits.
Training sessions (including remote and eLearning), user guides, video tutorials, certified trainer support and 24/7 customer care for device setup, troubleshooting and effective use.
Collection and recycling pilot for used disposable device components to reduce device waste in pilot regions.
Membership program offering community newsletters, opportunities to participate in surveys and share user experience to inform product development and support outreach.
Expertise Areas
- Automated insulin delivery and closed‑loop control
- Wearable medical device hardware and disposable pump manufacturing
- CGM interoperability and sensor integration
- Clinical study design and evidence generation for diabetes devices
Key Technologies
- Closed‑loop insulin delivery algorithms
- Predictive glucose modeling
- Bolus calculation algorithms (IOB, carbs, trend‑based)
- Interoperable continuous glucose monitoring (iCGM) integration
News & Updates
Study in people with type 1 diabetes comparing standard therapy and 3 months of automated mode use; reported improvements in A1c, time in range and reductions in hypoglycaemia metrics.
Study in very young children (ages 2–5.9) assessing automated mode use versus standard therapy with reported improvements in time in range and A1c.
Prospective pivotal trial in adults with type 2 diabetes including a hybrid closed‑loop phase reporting reductions in mean HbA1c and increases in time in range.
Study in people with type 1 diabetes comparing standard therapy and 3 months of automated mode use; reported improvements in A1c, time in range and reductions in hypoglycaemia metrics.
Study in very young children (ages 2–5.9) assessing automated mode use versus standard therapy with reported improvements in time in range and A1c.
Prospective pivotal trial in adults with type 2 diabetes including a hybrid closed‑loop phase reporting reductions in mean HbA1c and increases in time in range.